. . "It wasn't necessarily that the information was misleading, but that it would lead patients to make decisions about their own care without necessarily consulting a doctor, which the FDA thinks is not a good idea -- and I totally see their point, frankly.For example, one of the things that 23andMe can tell you is how well you might respond to one drug versus another, because of your specific genetic" . .